Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial.
Publication
, Journal Article
Khan, LA; Khan, MS; Ambrosy, AP; Greene, SJ
Published in: Heart Fail Rev
September 2024
Duke Scholars
Published In
Heart Fail Rev
DOI
EISSN
1573-7322
Publication Date
September 2024
Volume
29
Issue
5
Start / End Page
1157 / 1160
Location
United States
Related Subject Headings
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Humans
- Enzyme Inhibitors
- Diabetic Cardiomyopathies
- Cardiovascular System & Hematology
- Aldehyde Reductase
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Khan, L. A., Khan, M. S., Ambrosy, A. P., & Greene, S. J. (2024). Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial. Heart Fail Rev, 29(5), 1157–1160. https://doi.org/10.1007/s10741-024-10427-5
Khan, Laibah Arshad, Muhammad Shahzeb Khan, Andrew P. Ambrosy, and Stephen J. Greene. “Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial.” Heart Fail Rev 29, no. 5 (September 2024): 1157–60. https://doi.org/10.1007/s10741-024-10427-5.
Khan LA, Khan MS, Ambrosy AP, Greene SJ. Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial. Heart Fail Rev. 2024 Sep;29(5):1157–60.
Khan, Laibah Arshad, et al. “Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial.” Heart Fail Rev, vol. 29, no. 5, Sept. 2024, pp. 1157–60. Pubmed, doi:10.1007/s10741-024-10427-5.
Khan LA, Khan MS, Ambrosy AP, Greene SJ. Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial. Heart Fail Rev. 2024 Sep;29(5):1157–1160.
Published In
Heart Fail Rev
DOI
EISSN
1573-7322
Publication Date
September 2024
Volume
29
Issue
5
Start / End Page
1157 / 1160
Location
United States
Related Subject Headings
- Treatment Outcome
- Randomized Controlled Trials as Topic
- Humans
- Enzyme Inhibitors
- Diabetic Cardiomyopathies
- Cardiovascular System & Hematology
- Aldehyde Reductase
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology